Cargando…

Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism

There is increasing evidence for a role of inflammation in Parkinson’s disease. Recent research in murine models suggests that parkin and PINK1 deficiency leads to impaired mitophagy, which causes the release of mitochondrial DNA (mtDNA), thereby triggering inflammation. Specifically, the CGAS (cycl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borsche, Max, König, Inke R, Delcambre, Sylvie, Petrucci, Simona, Balck, Alexander, Brüggemann, Norbert, Zimprich, Alexander, Wasner, Kobi, Pereira, Sandro L, Avenali, Micol, Deuschle, Christian, Badanjak, Katja, Ghelfi, Jenny, Gasser, Thomas, Kasten, Meike, Rosenstiel, Philip, Lohmann, Katja, Brockmann, Kathrin, Valente, Enza Maria, Youle, Richard J, Grünewald, Anne, Klein, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586086/ https://www.ncbi.nlm.nih.gov/pubmed/33029617 http://dx.doi.org/10.1093/brain/awaa246

Ejemplares similares

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease
por: Trinh, Joanne, et al.
Publicado: (2022)

Discordance in monozygotic Parkinson's disease twins – continuum or dichotomy?
por: Balck, Alexander, et al.
Publicado: (2019)

Systematic Functional Analysis of PINK1 and PRKN Coding Variants
por: Broadway, Benjamin J., et al.
Publicado: (2022)

Comment on “mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC”
por: Ganley, Ian G., et al.
Publicado: (2021)

Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
por: Hou, Xu, et al.
Publicado: (2023)

Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2
por: Bras, Jose, et al.
Publicado: (2008)

Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early‐onset Parkinson’s disease
por: Ton, Nguyen Dang, et al.
Publicado: (2020)

Head impulse testing in bilateral vestibulopathy in patients with genetically defined CANVAS
por: Borsche, Max, et al.
Publicado: (2022)

Two different axes CALCOCO2-RB1CC1 and OPTN-ATG9A initiate PRKN-mediated mitophagy
por: Yamano, Koji, et al.
Publicado: (2020)

Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers
por: Castelo Rueda, Maria Paulina, et al.
Publicado: (2023)

Mitochondrial Mechanisms of LRRK2 G2019S Penetrance
por: Delcambre, Sylvie, et al.
Publicado: (2020)

Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions
por: Usnich, Tatiana, et al.
Publicado: (2023)

Parkin and PINK1 mitigate STING-induced inflammation
por: Sliter, Danielle A., et al.
Publicado: (2018)

Frequency of Heterozygous Parkin (PRKN) Variants and Penetrance of Parkinson's Disease Risk Markers in the Population-Based CHRIS Cohort
por: Castelo Rueda, Maria Paulina, et al.
Publicado: (2021)

An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial
por: Prasuhn, Jannik, et al.
Publicado: (2019)

Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
por: Föh, Bandik, et al.
Publicado: (2021)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
por: Mulica, Patrycja, et al.
Publicado: (2023)

Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts
por: Rakovic, Aleksandar, et al.
Publicado: (2011)

GAK and PRKCD are positive regulators of PRKN-independent mitophagy
por: Munson, Michael J., et al.
Publicado: (2021)

The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021)

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)

Assessing the relationship between monoallelic PRKN mutations and Parkinson’s risk
por: Lubbe, Steven J, et al.
Publicado: (2021)

PINK1-Interacting Proteins: Proteomic Analysis of Overexpressed PINK1
por: Rakovic, Aleksandar, et al.
Publicado: (2011)

Transition to endemic: 2-year SARS-CoV-2 surveillance follow-up of the ELISA cohort
por: Föh, Bandik, et al.
Publicado: (2023)

Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2022)

PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol
por: Sekine, Shiori, et al.
Publicado: (2018)

Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2015)

Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations
por: Kano, Masayoshi, et al.
Publicado: (2020)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)

A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China
por: Li, Hong-xing, et al.
Publicado: (2023)

Two Different PRKN Compound Heterozygous Variants Combinations in the Same Family
por: Biehler, Margaux, et al.
Publicado: (2023)

Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
por: Bispo, Ana Gabrielle, et al.
Publicado: (2023)

Molecular characterization of PRKN structural variations identified through whole‐genome sequencing
por: Bravo, Paloma, et al.
Publicado: (2018)

Prkn knockout mice show autistic-like behaviors and aberrant synapse formation
por: Huo, Yuda, et al.
Publicado: (2022)

The Amsterdam Preoperative Anxiety and Information Scale (APAIS) - the first trial of a German version
por: Berth, Hendrik, et al.
Publicado: (2007)

Profiling the Biochemical Signature of GBA‐Related Parkinson's Disease in Peripheral Blood Mononuclear Cells
por: Avenali, Micol, et al.
Publicado: (2021)

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma
por: Yao, Jingyue, et al.
Publicado: (2021)

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
por: Avenali, Micol, et al.
Publicado: (2020)

Associations of PRKN–PACRG SNPs and G × G and G × E interactions with the risk of hyperlipidaemia
por: Zheng, Peng-Fei, et al.
Publicado: (2020)

Levodopa-responsive dystonia caused by biallelic PRKN exon inversion invisible to exome sequencing
por: Mor-Shaked, Hagar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6grpog1lnaco72b09sn5rbcvan